# LENZ Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Jun 12, 2025

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: SCHEDULE 13D/A
- Filed: 2025-06-12
- Accepted by EDGAR: Jun 12, 2025, 16:49 ET
- Period: not reported
- Accession: 0000950170-25-085511
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000095017025085511/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000095017025085511/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000095017025085511/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Jun 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000950170-25-085511. Last ingested by Listed: Nov 4, 2026, 16:19 ET. No prices; not investment advice.